File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Effects of atrasentan on markers of liver function in patients with type 2 diabetes and chronic kidney disease

TitleEffects of atrasentan on markers of liver function in patients with type 2 diabetes and chronic kidney disease
Authors
Kohan, DELiew, ATang, SCWBarratt, JHeerspink, HJL
Keywordsdiabetic nephropathy
liver
randomized trial
type 2 diabetes
Issue Date1-Aug-2023
PublisherWiley
Citation
Diabetes, Obesity and Metabolism, 2023, v. 25, n. 8, p. 2410-2412 How to Cite?
DOI: http://dx.doi.org/10.1111/dom.15103
Persistent Identifierhttp://hdl.handle.net/10722/338817
ISSN
1462-8902
2021 Impact Factor: 6.408
2020 SCImago Journal Rankings: 2.445

 

DC FieldValueLanguage
dc.contributor.authorKohan, DE-
dc.contributor.authorLiew, A-
dc.contributor.authorTang, SCW-
dc.contributor.authorBarratt, J-
dc.contributor.authorHeerspink, HJL-
dc.date.accessioned2024-03-11T10:31:46Z-
dc.date.available2024-03-11T10:31:46Z-
dc.date.issued2023-08-01-
dc.identifier.citationDiabetes, Obesity and Metabolism, 2023, v. 25, n. 8, p. 2410-2412-
dc.identifier.issn1462-8902-
dc.identifier.urihttp://hdl.handle.net/10722/338817-
dc.languageeng-
dc.publisherWiley-
dc.relation.ispartofDiabetes, Obesity and Metabolism-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectdiabetic nephropathy-
dc.subjectliver-
dc.subjectrandomized trial-
dc.subjecttype 2 diabetes-
dc.titleEffects of atrasentan on markers of liver function in patients with type 2 diabetes and chronic kidney disease-
dc.typeArticle-
dc.identifier.doi10.1111/dom.15103-
dc.identifier.scopuseid_2-s2.0-85158025307-
dc.identifier.volume25-
dc.identifier.issue8-
dc.identifier.spage2410-
dc.identifier.epage2412-
dc.identifier.eissn1463-1326-
dc.identifier.issnl1462-8902-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats